A small, cross-functional team of chemists, neuroscientists, and biotech operators with decades of experience bringing CNS therapies from discovery through clinical development.
Biochemist and neurochemist with 25+ years in CNS drug development. Early scientist at BioMarin and co-founder of Raptor Pharmaceuticals. Sara led the discovery of Capton® technology and brings deep translational and regulatory expertise to Enabled's mission.
Inventor of Capton® technology and expert in redox biology and drug design. Former senior scientist at BioMarin and co-founder of Raptor Pharmaceuticals, Todd brings decades of CNS drug discovery experience and a uniquely creative scientific vision.
Biotech strategist with extensive experience in business development, investor relations, portfolio strategy, and company building. Brett brings strategic and fundraising expertise to Enabled's growth.
Entrepreneur and advisor with deep experience in scaling technology and life sciences companies. Jivan provides strategic leadership, investor relations guidance, and supports Enabled's governance and growth trajectory.
A seasoned entrepreneur and early investor in neuroscience innovation. As a co-founder and board member, he brings financial insight and long-term vision to Enabled's leadership.
Co-founder and CSO, Todd also serves on Enabled's Board of Directors, bringing scientific and technical leadership to governance decisions.
Physician-scientist and biotech leader with 30+ years in CNS and rare disease development. Dr. Weinstein has served as CMO, CEO, and VP of Clinical Development across multiple companies, bringing deep expertise in translational research, trial design, and regulatory strategy.
Reach out to discuss Enabled Therapeutics' platform, pipeline, or partnership opportunities.
Contact Us